Avery Dennison Acquires Finesse Medical
May 22 2017 - 11:00AM
Business Wire
Irish-based company brings new products,
manufacturing capabilities in high-value healthcare materials
business
Avery Dennison Corporation (NYSE:AVY) announced today that it
has acquired Finesse Medical Ltd., an innovator in the development
and manufacture of healthcare products used in the management of
wound care and skin conditions.
Headquartered in Longford, Ireland, Finesse Medical specializes
in the development and application of advanced technologies in
wound care and skin treatment, including skin barrier films and
protection creams, and silicone and polyurethane foam wound
dressings. With revenue over the last year of approximately €15
million, the company is a key supplier to global healthcare-product
OEMs and also provides contract manufacturing and product
development services.
“Finesse Medical is a top quality manufacturer with a strong
track record for developing and commercializing effective,
high-value products in the medical sector,” said Mitch Butier,
Avery Dennison’s president and CEO. “This acquisition will
accelerate the achievement of our long-term strategic and financial
goals for our industrial and healthcare materials segment.”
“Finesse Medical is a great strategic fit with Vancive Medical
Technologies,” added Mike Johansen, vice president and general
manager of Avery Dennison’s Industrial and Healthcare Materials
group. “Its innovative portfolio of silicone gels and polyurethane
foam dressings builds on and complements our existing products in
wound care. And its converting and packaging capabilities will
enable us to offer expanded manufacturing services to our
customers.”
“Uniting our two healthcare businesses is a strategic win for
both organizations and our global customer base,” said Martin Dowd,
director, marketing & business development, at Finesse Medical.
“Our companies share a strong commitment to quality, service and
innovation. Avery Dennison brings important new strengths to our
business, including key relationships in the U.S. healthcare
industry, new global sales and distribution channels for our
products, and coating and roll manufacturing expertise that deepens
our service offerings.”
About Avery Dennison
Avery Dennison (NYSE: AVY) is a global leader in
pressure-sensitive and functional materials and labeling solutions
for the retail apparel market. The company’s applications and
technologies are an integral part of products used in every major
industry. With operations in more than 50 countries and more than
25,000 employees worldwide, Avery Dennison serves customers in the
consumer packaging, graphical display, logistics, apparel,
industrial and healthcare industries. Headquartered in Glendale,
California, the company reported sales of $6.1 billion in 2016.
Learn more at www.averydennison.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170522005233/en/
Avery Dennison Media ContactRob Six,
626-304-2361rob.six@averydennison.comorAvery Dennison Investor
Relations ContactGarrett Gabel,
626-304-2399investorcom@averydennison.com
Avery Dennison (NYSE:AVY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Avery Dennison (NYSE:AVY)
Historical Stock Chart
From Sep 2023 to Sep 2024